Role of CD69 in the pathogenesis of elastase-induced pulmonary inflammation and emphysema  by Fujita, Tetsuo et al.




E-mjournal homepage: www.elsevier.com/locate/bbrepRole of CD69 in the pathogenesis of elastase-induced pulmonary
inﬂammation and emphysema
Tetsuo Fujita a,b, Kento Yoshioka b,c, Hiroki Umezawa a,b, Kensuke Tanaka a,b,
Yusuke Naito a,b, Toshinori Nakayama d, Masahiko Hatano c, Koichiro Tatsumi a,
Yoshitoshi Kasuya b,c,n
a Department of Respirology, Chiba University, Chiba 260-8670, Japan
b Department of Biochemistry and Molecular Pharmacology, Chiba University, Chiba 260-8670, Japan
c Department of Biomedical Science, Chiba University, Chiba 260-8670, Japan
d Department of Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japana r t i c l e i n f o
Article history:
Received 30 December 2015
Received in revised form
19 June 2016
Accepted 13 July 2016
Available online 16 July 2016
Keywords:
CD69




08/& 2016 The Authors. Published by Elsevier
esponding author at: Department of Bioche
y, Chiba University, Chiba 260-8670, Japan.
ail address: kasuya@faculty.chiba-u.jp (Y. Kasua b s t r a c t
Cluster of differentiation 69 (CD69), known as an early activation marker of lymphocytes, has been
demonstrated to regulate inﬂammatory events in various disease models. Although the increased
number of CD69-expressed T lymphocytes in the lungs of patients with chronic obstructive pulmonary
disease (COPD) has been reported, a functional role of CD69 in the pathogenesis of COPD remains un-
known. To address to this question, CD69-deﬁcient (CD69KO) mice and wild-type (WT) mice were
subjected to a mouse model of porcine pancreatic elastase (PPE)-induced pulmonary inﬂammation and
emphysema. In the two genotypes, PPE increased counts of macrophages, neutrophils and lymphocytes
in bronchoalveolar lavage ﬂuid (BALF) and induced emphysematous changes in the lung, whereas those
two pathological signs were signiﬁcantly enhanced in CD69KO mice compared to WT mice. Moreover,
the PPE-induced levels of IL-17 and IL-6 in BALF were signiﬁcantly higher in CD69KO mice than in WT
mice at the acute inﬂammatory phase. Immunoﬂuorescent studies showed that IL-17 and IL-6 were
predominantly expressed in CD4þ and γδ T cells and macrophages, respectively. Concomitant admin-
istration of IL-17- and IL-6-neutralizing antibodies signiﬁcantly attenuated the PPE-induced emphyse-
matous changes in the two genotypes. These ﬁndings suggest that CD69 negatively regulates the de-
velopment of PPE-induced emphysema in part at least through modulating function of IL-17-producing T
cells.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Chronic obstructive pulmonary disease (COPD) is a global health
problem, which is predicted to be the third leading cause of death
worldwide by 2020 [1]. COPD is characterized by chronic in-
ﬂammation of the small airways and disruption of the alveolar walls,
leading to small airway remodeling and airspace enlargement [2].
Although the main strategy for treating COPD is to control of chronic
inﬂammation, current anti-inﬂammatory therapies are not success-
ful [3]. Therefore, there is an emerging need for identiﬁcation of new
key inﬂammatory regulators in COPD.
CD69, a type II membrane protein with a C-type lectin biding
domain [4], is known to be an early T lymphocyte activation markerB.V. This is an open access article u
mistry and Molecular Phar-
ya).that is upregulated in response to inﬂammatory stimuli [5]. The
pathophysiological roles of CD69 in various inﬂammatory disease
models have been studied using CD69-deﬁcient (KO) mice [6–9].
CD69 has been reported to be associated with JAK3/Stat5 protein and
negatively control Th17 cell differentiation as a receptor for Galectin-
1 on dendritic cells [10,11]. These ﬁndings suggest that CD69 can
function as a negative modulator in the pathogenesis of several
autoimmune diseases [6]. In contrast, CD69 plays an active role in
several animal models of inﬂammatory disease [7–9]. Hence, the
controversial contribution of CD69-deﬁciency to inﬂammatory out-
put of various disease models makes the CD69 function complicated.
To employ CD69 as a feasible therapeutic option, information con-
cerning functional role of CD69 in the different inﬂammatory dis-
eases should be accumulated.
Recently, it has been revealed that CD69 expression on both
lung CD4þ and CD8þ T cells correlates with COPD severity [12,13],
tempting us to consider that CD69 might be involved in the pro-
gression of COPD. However, the mechanism how CD69-expressednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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sema, is still unknown. Here, we investigated the role of CD69 in
the pathogenesis of COPD by subjecting CD69KO and wild-type
(WT) mice to a mouse model of elastase-induced emphysema.2. Materials and methods
2.1. Mice and treatment
CD69KO mice (C57BL/6 background) were generated as pre-
viously described [8]. WT and CD69KO littermates aged 8–12
weeks were used for each experiment. All animal procedures
conformed to the Japanese regulations for animal care and use,
following the Guidelines for Animal Experimentation of the Japa-
nese Association for Laboratory Animal Science, and were ap-
proved by the Animal Care and Use Committee of Chiba University.
Mice under anesthesia were given a single intratracheal injec-
tion of porcine pancreatic elastase (PPE) (0.2 U/g, Elastin Products
Company, Owensville, MO) dissolved in phosphate-buffered saline
(PBS) by using a Microsprayer atomizer (Penn-Century, Philadel-
phia, PA). Control mice were treated with PBS. In some experi-
ments, mice received intratracheal injection of anti-mouse IL-17A-
neutralizing antibody (10 mg/body, Biolegend, San Diego, CA) and
anti-mouse IL-6-neutralizing antibody (10 mg/body, Biolegend)
concurrently with instillation of PPE. Control mice were treated
with isotype control (rat IgG1κ, R&D Systems, Minneapolis, MN) in
PBS.
2.2. Evaluation of cell populations and cytokines in BALF
At 1 day post-instillation (dpi), the trachea was exposed and
lavaged three times with 1 ml PBS using a 20-gauge catheter. After
centrifuging BALF at 400 g for 10 min, the resulting supernatants
were stored as samples for ELISA at 80 °C, and the cell pellet was
resuspended in PBS and subjected to the cell count using a he-
mocytometer in combination with Diff-Quick (Sysmex Corpora-
tion, Kobe, Japan) staining. The levels of IFN-γ, IL-17A, IL-6 and IL-
23 in BALF were measured by ELISA kit (Biolegend) according to
the manufacturer's protocols.
2.3. Histological examination
At 21 dpi, mice under anesthesia were intracardially perfused
with ice-cold PBS, and lung tissue was inﬂated and ﬁxed by infu-
sion of 4% paraformaldehyde (PFA) through the tracheal cannula at
a constant pressure of 20 cm of H2O. The left lung was dissected
out, ﬁxed, dehydrated and frozen. Freshly cut lung sections (5 mm
thickness) placed on poly-L-lysine-coated slides were stained with
hematoxylin-eosin (HE). Airspace enlargement was quantiﬁed by
the mean linear intercept (MLI) calculations in 20 randomly se-
lected ﬁelds of the lung tissue sections. MLI was obtained by di-
viding the total length of a line drawn across the lung section by
the total number of intercepts encountered.
2.4. Immunoﬂuorescent study
Freshly cut lung sections (5 mm thickness) from mice at 1 dpi
were pretreated with FcR blocking agent (Miltenyi Biotec, Glad-
bach, Germany) for 15 min, and then reacted with various anti-
bodies as follow: anti-mouse IL-6 antibody (Biolegend), anti-
mouse IL-17A (Biolegend), anti-Iba1 antibody (WAKO, Osaka, Ja-
pan), anti-CD4 antibody (BIOSS ANTIBODIES, Boston, Massachu-
setts) and anti-mouse T-cell receptor (TCR)γδ antibody (Biole-
gend). After staining with each appropriate ﬂuorescein-conjugated
second antibody, the sections were observed under a ﬂuorescencemicroscope (Axio ImagerA2, Zeiss, Oberkochen, Germany). Nuclei
were stained with 4′, 6-diamidino-2-phenylindole (DAPI). In case
of counting IL-6-, IL-17-, Iba1-, CD4 and TCRγδ-like im-
munoreactivity (LI), two sections from each lung were randomly
selected and subjected to immunoﬂuorescent studies. Under
200 magniﬁcation, 3 ﬁelds in each section were randomly
chosen, and ﬂuorescent signal-expressing cells were counted and
averaged (/0.1 mm2).
2.5. Intracellular IL-17 staining
At 1 and 3 dpi, single cell suspensions of lymph node cells
(LNCs) were prepared from the cervical and axillary lymph nodes
of WT and CD69KO mice and stimulated with 50 ng/ml phorbol
12-myristate 13-acetate (PMA) plus 2 μg/ml ionomycin for 3 h in
the presence of 2 mM monensin (Sigma, St. Louis, MO). Then, the
cells were stained with allophycocyanin-conjugated CD4 antibody
(Biolegend). After ﬁxing and permeabilizing (Fix/Perm buffer,
Biolegend), the cells were further stained with phycoerythrin-
conjugated anti-IL-17 antibody and FITC-conjugated anti-IFN-γ
antibody (BD Biosciences, San Jose, CA). Analysis was performed
with a FACS CantII ﬂow cytometer (BD Biosciences) and FlowJo
software (Tree Star Inc., Ashland, OR, USA).
2.6. Evaluation of IL-17 production in γδ T cells
To purify γδ T cells, CD4þ T cells were ﬁrst depleted from single
cell suspensions of the LNCs derived from naïve WT and CD69KO
mice by using anti-mouse CD4 magnetic microbeads (Miltenyi
Biotec, Gladbach, Germany) in combination with MACS columns
(Miltenyi Biotec). It has been demonstrated that activated γδ T
cells amplify Th17 response [14]. Hence, this CD4þ cell-depletion
step can minimize the participation of Th17-derived IL-17 in the
assay. Then, the CD4 LNCs were incubated with FITC-conjugated
anti-mouse TCRγδ antibody (eBioscience, Santa Clara, CA) fol-
lowed by a reaction with anti-FITC magnetic microbeads (Miltenyi
Biotec). The cells selected by MACS columns were used as γδ T
cells and cultured in RPMI 1640 medium (Sigma) supplemented
with 10% FBS, 500 mM 2-mercaptoethanol, penicillin (100 units/
ml), and streptomycin (100 mg/ml) for 24 h at 37 °C in a humidiﬁed
atmosphere (5% CO2). Then, according to a previous report [14], γδ
T cells were stimulated with IL-1β (10 ng/ml) and IL-23 (10 ng/ml)
for 72 h. The supernatants were subjected to enzyme-linked im-
munosorbent assay (ELISA) for mouse IL-17A (Biolegend). We
conﬁrmed that IL-17A levels in the supernatants from un-
stimulated γδ T cells of the two genotypes were below the de-
tection limit.
2.7. Statistical analysis
Data are shown as mean7S.E.M. Statistical analysis was con-
ducted using GraphPad Prism software (Version 6.0: GraphPad
Software Inc., San Diego). Statistical signiﬁcance was determined
by one-way ANOVA, followed by the Tukey test. A p value o0.05
was considered to be signiﬁcant.3. Results and discussion
3.1. Deterioration of elastase-induced pulmonary emphysema in
CD69KO mice
It has been clearly demonstrated that CD69 is expressed on
activated lymphocytes, neutrophils and macrophages in various
inﬂammatory diseases [5,8,9,15]. Also in the PPE model, PPE ap-
parently increased the numbers of CD69þ/Iba1þ , CD69þ/Ly6Gþ ,
Fig. 1. Pathophysiological proﬁles of CD69KO mice in elastase-induced lung inﬂammation and subsequent emphysematous change. A) Effect of PPE-instillation on differ-
ential cell counts in WT and CD69KO mice. Time-dependent changes of differential cell counts in BALF were determined 1 d after the instillation of PPE (0.2 U/g body weight)
or PBS. Data are shown as mean7S.E.M. (n¼4–8). *Po0.05, signiﬁcantly different from value of WT-PBS group (ANOVA followed by Tukey's test). The difference between
WT-PPE and CD69KO-PPE groups was statistically signiﬁcant (#Po0.05). B) Typical proﬁles of histopathological changes in the lung of WT and CD69KO mice. Lung sections
from WT and CD69KO mice at 21 dpi were stained with hematoxylin and eosin. Scale bar represents 100 mm. C) Mean linear intercept (MLI), as a measure of interalveolar
wall distance, was determined by light microscopy. Data are shown as mean7S.E.M. (n¼8). *Po0.05, signiﬁcantly different from value of WT-PBS group (ANOVA followed
by Tukey's test).
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that PPE-mobilized inﬂammatory cells such as macrophages,
neutrophils and T lymphocyte subsets upregulate CD69 expression
(Supplemental Fig. 1). Hence, to elucidate how CD69 controls the
progression of lung inﬂammation followed by emphysematous
changes, WT and CD69KO mice were subjected to the PPE-induced
COPD model. As shown in Fig. 1A, the numbers of total in-
ﬂammatory cells, neutrophils, macrophages, and lymphocytes in
BALF were signiﬁcantly elevated by PPE in the both genotypes in a
time-dependent manner with showing a peak level of each cell
population. The increase in these cell populations in PPE-instilled
mice was signiﬁcantly enhanced in CD69KO mice. It has been re-
ported that the initial inﬂammatory output induced by PPEcorrelates with severity of subsequent pulmonary emphysematous
changes [16,17]. As shown in Fig. 1B, PPE induced apparent em-
physematous changes in the lung of both genotypes at 21 dpi,
which were much severe in CD69KO mice compared with WT
mice (Fig. 1B). Accordingly, the PPE-increased MLI was sig-
niﬁcantly higher in CD69KO mice than in WT mice (Fig. 1C). These
results suggest that CD69 may play an inhibitory role in the elas-
tase-induced pulmonary pathology.
Previous reports have demonstrated that elastase-induced lung
injury leads production of various cytokines/chemokines, such as
Eotaxin, MIP-1α, TNF-α, KC, IL-1β, IL-6, MIP-2 and IL-17. These
cytokines are acutely expressed in response to the PPE adminis-
tration, and some of them showed a peak expression level at 1 dpi
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ciency, IL-6-deﬁciency, MyD88 (IL-1R1 adapter protein)-deﬁciency
or IL-17-deﬁciency can attenuate the PPE-induced acute lung in-
ﬂammation and subsequent emphysema [16–19]. Thus, the PPE-
upregulated cytokines at the acute inﬂammatory phase positively
contribute to the development of emphysema. Therefore, next, to
elucidate the mechanisms underlying the enhanced signs of
CD69KO mice, we investigated levels of various cytokines in BALF
from WT and CD69KO mice at 1 dpi.
3.2. Involvement of IL-6 and IL-17 and their signals-associated cy-
tokines in the enhanced signs of CD69KO mice
Lymphoid follicles composed of B-cell core, T cells in the per-
iphery and dendritic cells presenting antigen are occasionally ob-
served in the lungs of patients with COPD, indicating that T cells
affect the pathogenesis of COPD [20]. Similarly, chronic in-
ﬂammation mediated by Th1- and Th17-signals-associated cyto-
kines has been shown to be associated with the development of
COPD [21–23]. Therefore, we examined expression levels of IFN-γ
and IL-17 that are key mediators of Th1- and Th17-related in-
ﬂammation, respectively, in BALF from the two genotypes at 1 dpi.
As shown in Fig. 2, the level of IL-17 induced by PPE was higher in
CD69KO mice than WT mice. On the other hand, IFN-γ level in
BALF was not induced by PPE in the two genotypes, suggesting
that IL-17-producing T cells but not Th1 cells may be involved in
the enhanced signs of CD69KO mice. It is well known that IL-6 and
IL-23 are key mediators for the differentiation of Th17 and IL-17-
producing γδ T cells [24,25]. Then, the amounts of IL-6 and IL-23 in
BALF were also examined. IL-6 was induced by the PPE challenge,
and its level was signiﬁcantly higher in CD69KO mice than WTFig. 2. Changes in cytokine levels in BALF from WT and CD69KO mice.
Concentrations of IFN-γ, IL-17A, IL-6 and IL-23 in BALF from the two genotypes at 1 d
signiﬁcantly different from value of WT-PBS group (ANOVA followed by Tukey's test).mice. On the other hand, IL-23 was not induced by PPE in the two
genotypes. These results provide the possibility that CD69 may
modulate the development of COPD partly through regulating IL-
6/IL-17-signaling axis.
In mouse models of COPD evoked by PPE and cigarette smoking
(CS), various cytokines/chemokines sensitive to IL-17 or IL-6 co-
ordinately contribute to the development of COPD. In IL-6-deﬁ-
cient mice, the PPE-induced MIP-1α is signiﬁcantly suppressed in
BALF compared to WT mice [18]. In the PPE and the CS models, the
induction of MIP-2, IL-1β and G-CSF levels in BALF from IL-17-
deﬁcient mice was less than that from WT mice [17,26]. Likewise,
IL-17RA-deﬁciency failed to induce MCP-1, RANTES and IP-10
compared to WT mice [27]. Concerning these IL-6/IL-17-signals-
associated cytokines/chemokines, we evaluated the effect of CD69-
deﬁciency on their expression in the PPE model by performing a
cytokine array. As expected, all of the PPE-induced levels of IL-6/
IL-17-signals-associated cytokines/chemokines (G-CSF, IL-1β, IP-
10, MCP-1, MIP-1α, MIP-2 and RANTES) in BALF were higher in
CD69KO mice than WT mice (Supplemental Fig. 2). Hence, various
cytokines sensitive to the upregulation of IL-6/IL-17 signaling co-
ordinately contribute to the enhanced signs of CD69KO mice. Then,
we investigated the sources of the key cytokines, IL-6 and IL-17 in
the PPE-instilled lung.
3.3. 3.3. IL-6- and IL-17-producing cells in the PPE-instilled lung
As shown in Fig. 3A, the PPE-induced IL-6-LI was pre-
dominantly observed in Iba1þ cells in the alveolar space at 1 dpi,
which was apparent in the lung of CD69KO mice compared to WT
mice. Accordingly, the number of IL-6þ Iba1þ cells was increased
in the alveolar space of the two genotypes instilled with PPE,pi were determined by ELISA. Data are shown as mean7S.E.M. (n¼6). *Po0.05,
Fig. 3. Immunoﬂuorescent study for IL-6- and IL-17-producing cells in WT and CD69KO mice. A) Predominant IL-6- and IL-17-producing cells in the lung of the two
genotypes instilled with PPE. Lung sections from WT and CD69KO mice at 1 dpi were reacted with the designated combination of antibodies. Asterisks indicate double-
positive cells. Scale bar represents 50 mm. B) The PPE-increased and CD69-deﬁcinecy-sensitive IL-6þ Iba1þ , IL-17þCD4þ and IL-17þTCRγδþ cells. Data are shown as
mean7S.E.M. (n¼8). *Po0.05, signiﬁcantly different from value of WT-PBS group (ANOVA followed by Tukey's test).
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mice was signiﬁcantly larger than that in WT mice (Fig. 3B). Al-
though the PPE-induced IL-6-LI was also observed in SP-Cþ al-
veolar epithelial cell type II and S100A4þ ﬁbroblast as small po-
pulations, there was no signiﬁcant difference in the numbers of
IL-6þSP-Cþ and IL-6þS100A4þ cells between the two genotypes
(data not shown). These ﬁndings indicate that a predominant IL-6-
producing cell is macrophage under our experimental condition
and further suggest that the PPE-induced inﬁltration of macro-
phages producing IL-6 into the lung can be sensitive to the CD69-
deﬁciency. On the other hand, IL-17-LI was mostly observed in
CD4þ and TCRγδþ lymphocytes in the lungs of the two genotypes
after instillation of PPE (Fig. 3A). The PPE-increased numbers of
IL-17þCD4þ and IL-17þTCRγδþ cells in CD69KO mice were sig-
niﬁcantly larger than those in WT mice (Fig. 3B), indicating that
PPE-mobilized IL-17-producing T cells could be enhanced by the
CD69-deﬁciency. Although Th17 and regulatory T cells are re-
cognized as IL-17-producing CD4þ cells [28], IL-17þFoxp3þ cells
were merely observed in the PBS- or PPE-instilled mice (data not
shown). Therefore, the IL-17þCD4þ cells were Th17 cells. These
results suggest that Th17 and γδ T cells are predominant source of
IL-17 under the PPE-provoked inﬂammatory environment in the
lung and negatively modulated by CD69.The question arose as to whether the ability of each cell in pro-
ducing IL-6 or IL-17 might be regulated by CD69 signaling. Then, we
evaluated the changes of following ratios: IL-6þ Iba1þ/Iba1þ;
IL-17þCD4þ/CD4þ and IL-17þTCRγδþ/TCRγδþ in four groups (WT-
PBS, WT-PPE, CD69KO-PBS and CD69KO-PPE). As shown in Table 1,
all of the ratios of IL-6þ Iba1þ/Iba1þ , IL-17þCD4þ/CD4þ and
IL-17þTCRγδþ/TCRγδþ signiﬁcantly increased in response to PPE.
The IL-6þ Iba1þ/Iba1þ ratio showed no signiﬁcant difference be-
tween WT-PPE and CD69KO-PPE groups, suggesting that CD69 on
macrophages may not function as a regulator for IL-6 production at
least in the PPE model. In contrast, the ratios of IL-17þCD4þ/CD4þ
and IL-17þTCRγδþ/TCRγδþ in CD69KO-PPE group were sig-
niﬁcantly elevated compared with those in WT-PPE group. This
ﬁnding suggests that CD69 may be a negative regulator for IL-17-
producing T cell subsets, especially Th17 and γδ T cells, in the PPE
model. In fact, it has been demonstrated that CD69-mediated Jak3/
Stat5 signaling negatively affects the differentiation from naïve CD4þ
T cells into Th17 cells [11]. Moreover, it has been reported that the
inﬁltration of CD4þ T cells producing IL-17 into the lung can be in-
duced by the PPE instillation [17]. Then, we elucidated whether PPE
might affect the CD69-deﬁciency-sensitive Th17 polarization. As
shown in Fig. 4A, PPE increased the population of Th17 cells in the
lymph nodes at 1 and 3 dpi, which was signiﬁcantly higher in
Table 1
Effect of PPE on activity of IL-6- and IL-17-producing cells in the lung of WT and CD69KO mice.
WT-PBS WT-PPE CD69KO-PBS CD69KO-PPE
IL-6þ Iba1þ/Iba1þ 17.871.5 40.372.7n 20.071.8 43.773.6n
IL-17þCD4þ/CD4þ 10.673.2 23.771.8n 13.473.6 38.072.8n#
IL-17þTCRγδþ/ TCRγδþ 19.373.1 58.271.7n 19.472.3 68.073.0n# (%)
Data represent mean7S.E.M. of eight independent lung samples.
n Po0.05, signiﬁcantly different from PBS group in each genotype by Student's t-test.
# Po0.05, signiﬁcantly different from WT-PPE group by Student's t-test.
Fig. 4. IL-17-producing activity of Th17 and γδT cells from WT and CD69KO mice. A) The PPE-increased and CD69-deﬁcinecy-sensitive Th17 differentiation. Single cell
suspensions of LNCs from PPE-instilled WT and CD69KO mice at 1 and 3 dpi were stimulated with PMAþ ionomycin or PBS for 3 h and subjected to surface staining for CD4
and intracellular staining for IL-17 and IFN-γ. Quantiﬁcation of IL-17þCD4þ IFN-γ T cells was performed with FlowJo software. Data are shown as mean7S.E.M. (n¼4–6).
*Po0.05, signiﬁcantly different from value of WT-PBS group (ANOVA followed by Tukey's test). B) IL-17 production in γδ T cells from the two genotypes. TCRγδþ cells were
prepared from the lymph nodes of naïve WT and CD69KO mice and stimulated with IL-1βþ IL-23. The resulting supernatants were subjected to ELISA for mouse IL-17A. We
conﬁrmed that IL-17A levels in the supernatants from unstimulated γδ T cells of the two genotypes were below the detection limit. Data are shown as mean7S.E.M. (n¼6).
*Po0.05, signiﬁcantly different from value of WT group by Student's t test.
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stillation can induce the CD69-deﬁciency-sensitive Th17 differentia-
tion and support our present ﬁndings (Figs. 2 and 3, and Table 1). On
the other hand, the involvement of CD69 in IL-17-producing activity
of γδ T cells has been still unknown. Then, according to the previous
report [14], we evaluated IL-17 production from in vitro activated γδ
T cells between the two genotypes. As shown in Fig. 4B, IL-1β plus IL-
23 promoted IL-17 production in γδ T cells, which was signiﬁcantly
higher in CD69KO mice than WT mice. This ﬁnding suggests that
CD69 negatively regulates IL-17 production from not only Th17 cells
but γδ T cells.
Although a precise mechanism how CD69 controls IL-17-produ-
cing activity of γδ T cells is needed, γδ T cells are resident in the lung
with a high population and recognized as primary cells producing IL-
17 in autoimmune inﬂammatory disease [29]. Likewise, in addition
to lung-resident γδ T cells, circulating γδ T cells are known to change
their characteristics from an original phenotype as IFN-γ producers
to potent IL-17 producers at sites of inﬂammation [25]. Although it
has been reported that an increase of γδ T cell population in BALF or
peripheral blood correlates with smokers but not COPD patients, γδ
T cells have diverse subsets, and IL-17-producing γδ T cells show
bidirectional effects on inﬂammation [30,31]. Thus, further in-
formation concerning the relationship between IL-17-producing γδ T
cells and COPD is expected.
Taken together, Th17- and γδ T cell-derived IL-17 in concert
with macrophage-derived IL-6 may contribute to the enhancedemphysematous changes of CD69KO mice. Therefore, next, we
examined the effect of their neutralizing antibodies on the PPE-
induced emphysema.
3.4. Effect of IL-17- and IL-6-neutralization on elastase-induced
pulmonary emphysema
Typical histopathological changes in the lungs and MLI values
were shown in Fig. 5A and B, respectively. In the lungs from WT
mice, administration of IL-17-neutralizing antibody or IL-6-neu-
tralizing antibody showed a tendency to inhibit the PPE-induced
airspace enlargement at 21 dpi. However, the increase of MLI value
was not signiﬁcantly attenuated by each antibody. On the other
hand, concomitant administration of IL-17-neutralizing antibody
plus IL-6-neutralizing antibody markedly ameliorated the PPE-
induced destruction of alveolar walls and signiﬁcantly inhibited
the increase of MLI value at 21 dpi. In the lungs from CD69KO
mice, IL-17-neutralizing antibody or IL-6-neutralizing antibody
signiﬁcantly attenuated the PPE-increased MLI value at 21 dpi,
wherefore concomitant administration of them further attenuated
the PPE-induced emphysematous changes. These results indicate
that the sensitivity of PPE-induced airspace enlargement to
blockade of each cytokine could be higher in CD69KO mice than
WT mice. Therefore, the CD69-deﬁciency-associated enhancement
of IL-6 and IL-17 production may closely relate to the deterioration
of emphysematous changes in CD69KO mice.
Fig. 5. Effects of IL-6- and IL-17-neutralizing antibodies on elastase-induced lung emphysematous changes in WT and CD69KO mice. A) Typical histopathological changes of
the lungs. Scale bar represents 100 mm. B) MLI, an index of enlargement of alveolar airspaces. Data are shown as mean7S.E.M. (n¼4–6). *Po0.05, signiﬁcantly different from
value of WT-PBS group (ANOVA followed by Tukey's test).
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through recruitment of neutrophils [22]. Likewise, the degree of
airﬂow obstruction in patients with COPD is correlated with spu-
tum IL-17 concentrations [23]. Furthermore, the elevated IL-6 le-
vels in the serum are recognized as one of prognostic factors in
COPD [32]. Also in a mouse model of PPE-induced emphysema
using IL17- and IL-6-deﬁcient mice, each crucial role of IL-17 and
IL-6 in the pathogenesis of lung emphysematous changes has been
clearly demonstrated [17,18]. However, the independent admin-
istration of each neutralizing antibody for IL-17 or IL-6 could not
exert beneﬁcial effect in the case of WT mice in which the PPE-
induced emphysematous change was less severe compared with
CD69KO mice (Fig. 5). Considering anti-cytokine strategy in COPD,
blockade of both signals may be practical.
In an acute inﬂammatory model by short-term exposure of
cigarette smoke (CS), we have previously demonstrated that in-
ﬁltration of macrophages and neutrophils into the lung was atte-
nuated in CD69KO mice, which is controversial to the case of this
study [33]. In that model, emphysematous changes were not
brought about because of short-term CS exposure, and inﬁltration
of T lymphocytes was not observed. In particular, a cytokine array
analysis showed that IL-17 was not mobilized in the BALF. Hence,
the predominant involvement of IL-17-producing T cell may affect
the fate of bidirectional role of CD69 in the development of pul-
monary inﬂammation. Further study is needed for this point.4. Conclusion
We demonstrated that CD69 plays an important role in the
development of elastase-induced acute phase inﬂammation and
subsequent emphysematous change of the lung. Genetic blockade
of CD69 enhanced the elastase-induced emphysema, which was
associated with both increased inﬁltration of inﬂammatory cells
and upregulated levels of Th17- and γδ T cell-derived IL-17 and
macrophage-derived IL-6. These results, for the ﬁrst time, indicate
a protective role of CD69 signaling in the development of pul-
monary emphysema by PPE.Authors' contributions
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